An investigation into the performance of the Adjuvant! Online prognostic programme in early breast cancer for a cohort of patients in the United Kingdom

por Campbell, H E, Taylor, M A, Harris, A L, Gray, A M
Publicado 2009

Role of CT scan-based and clinical evaluation in the preoperative prediction of optimal cytoreduction in advanced ovarian cancer: a prospective trial

por Ferrandina, G, Sallustio, G, Fagotti, A, Vizzielli, G, Paglia, A, Cucci, E, Margariti, A, Aquilani, L, Garganese, G, Scambia, G
Publicado 2009

Inhibition of constitutive and cxc-chemokine-induced NF-κB activity potentiates ansamycin-based HSP90-inhibitor cytotoxicity in castrate-resistant prostate cancer cells

por Seaton, A, Maxwell, P J, Hill, A, Gallagher, R, Pettigrew, J, Wilson, R H, Waugh, D J J
Publicado 2009

CITED2 and NCOR2 in anti-oestrogen resistance and progression of breast cancer

por van Agthoven, T, Sieuwerts, A M, Veldscholte, J, Meijer-van Gelder, M E, Smid, M, Brinkman, A, den Dekker, A T, Leroy, I M, van IJcken, W F J, Sleijfer, S, Foekens, J A, Dorssers, L C J
Publicado 2009

In vitro activity of pertuzumab in combination with trastuzumab in uterine serous papillary adenocarcinoma

por El-Sahwi, K, Bellone, S, Cocco, E, Cargnelutti, M, Casagrande, F, Bellone, M, Abu-Khalaf, M, Buza, N, Tavassoli, F A, Hui, P, Silasi, D-A, Azodi, M, Schwartz, P E, Rutherford, T J, Pecorelli, S, Santin, A D
Publicado 2010

Cisplatin-induced expression of Gb3 enables verotoxin-1 treatment of cisplatin resistance in malignant pleural mesothelioma cells

por Johansson, D, Andersson, C, Moharer, J, Johansson, A, Behnam-Motlagh, P
Publicado 2010

False-positive screening results in the Finnish prostate cancer screening trial

por Kilpeläinen, T P, Tammela, T L J, Määttänen, L, Kujala, P, Stenman, U-H, Ala-Opas, M, Murtola, T J, Auvinen, A
Publicado 2010

The management and outcome of women with post-hydatidiform mole ‘low-risk’ gestational trophoblastic neoplasia, but hCG levels in excess of 100 000 IU l(−1)

por McGrath, S, Short, D, Harvey, R, Schmid, P, Savage, P M, Seckl, M J
Publicado 2010

Establishment and characterization of a new hypoxia-resistant cancer cell line, OCUM-12/Hypo, derived from a scirrhous gastric carcinoma

por Kato, Y, Yashiro, M, Noda, S, Tendo, M, Kashiwagi, S, Doi, Y, Nishii, T, Matsuoka, J, Fuyuhiro, Y, Shinto, O, Sawada, T, Ohira, M, Hirakawa, K
Publicado 2010

Inhibitory effect of a TGFβ receptor type-I inhibitor, Ki26894, on invasiveness of scirrhous gastric cancer cells

por Shinto, O, Yashiro, M, Kawajiri, H, Shimizu, K, Shimizu, T, Miwa, A, Hirakawa, K
Publicado 2010

Molecular characterisation of ERG, ETV1 and PTEN gene loci identifies patients at low and high risk of death from prostate cancer

por Reid, A H M, Attard, G, Ambroisine, L, Fisher, G, Kovacs, G, Brewer, D, Clark, J, Flohr, P, Edwards, S, Berney, D M, Foster, C S, Fletcher, A, Gerald, W L, Møller, H, Reuter, V E, Scardino, P T, Cuzick, J, de Bono, J S, Cooper, C S
Publicado 2010

Influence of pharmacogenetics on response and toxicity in breast cancer patients treated with doxorubicin and cyclophosphamide

por Bray, J, Sludden, J, Griffin, M J, Cole, M, Verrill, M, Jamieson, D, Boddy, A V
Publicado 2010

Oxaliplatin, irinotecan and capecitabine as first-line therapy in metastatic colorectal cancer (mCRC): a dose-finding study and pharmacogenomic analysis

por Zarate, R, Rodríguez, J, Bandres, E, Patiño-Garcia, A, Ponz-Sarvise, M, Viudez, A, Ramirez, N, Bitarte, N, Chopitea, A, Gacía-Foncillas, J
Publicado 2010

Age of mother and grandmother in relation to a subject's breast cancer risk

por de Haan, M C, Michels, K B, Peeters, P H M, van Noord, P A H, Hennekam, F A M, van der Schouw, Y T
Publicado 2010

Tamoxifen resistance in early breast cancer: statistical modelling of tissue markers to improve risk prediction

por Baneshi, M R, Warner, P, Anderson, N, Edwards, J, Cooke, T G, Bartlett, J M S
Publicado 2010

Patient satisfaction with GP-led melanoma follow-up: a randomised controlled trial

por Murchie, P, Nicolson, M C, Hannaford, P C, Raja, E A, Lee, A J, Campbell, N C
Publicado 2010

Novel HSP90 inhibitors, NVP-AUY922 and NVP-BEP800, radiosensitise tumour cells through cell-cycle impairment, increased DNA damage and repair protraction

por Stingl, L, Stühmer, T, Chatterjee, M, Jensen, M R, Flentje, M, Djuzenova, C S
Publicado 2010

Endogenous myoglobin in human breast cancer is a hallmark of luminal cancer phenotype

por Kristiansen, G, Rose, M, Geisler, C, Fritzsche, F R, Gerhardt, J, Lüke, C, Ladhoff, A-M, Knüchel, R, Dietel, M, Moch, H, Varga, Z, Theurillat, J-P, Gorr, T A, Dahl, E
Publicado 2010

UGT1A and TYMS genetic variants predict toxicity and response of colorectal cancer patients treated with first-line irinotecan and fluorouracil combination therapy

por Martinez-Balibrea, E, Abad, A, Martínez-Cardús, A, Ginés, A, Valladares, M, Navarro, M, Aranda, E, Marcuello, E, Benavides, M, Massutí, B, Carrato, A, Layos, L, Manzano, J L, Moreno, V
Publicado 2010

Co-expression of CD147 (EMMPRIN), CD44v3-10, MDR1 and monocarboxylate transporters is associated with prostate cancer drug resistance and progression

por Hao, J, Chen, H, Madigan, M C, Cozzi, P J, Beretov, J, Xiao, W, Delprado, W J, Russell, P J, Li, Y
Publicado 2010